消化肿瘤杂志-官方网站
过刊浏览

过刊浏览

onlinebrowsing

定量免疫粪便隐血试验联合危险度评估在社区结直肠癌筛查中的应用

Application of quantitative fecal immunochemical testing combined with risk assessment in colorectal cancer screening in community

发布日期:2023-10-28 11:14:11 阅读次数: 0 下载

 

作者:张杰


单位:苏州市吴江区第五人民 医院消化内科,江苏 苏州 215211

 

Authors:  Zhang Jie

 

Unit:  Department of Gastroenterology, the Fifth People’s Hospital of Wujiang, Suzhou 215211, Jiangsu, China

 

摘要:

目的  探讨定量免疫粪便隐血试验(fecal immunochemical testing, FIT)联合危险度评估在社区结直肠癌(colorectal cancer, CRC)筛查中的应用价值。方法  选择20229月至202212月在吴江区开展CRC筛查的人群为研究对象。评估结果为阳性的有613例;评估阳性的人群中有320例作为试验组(1次定性FIT+1次定量FIT),293例作为对照组(2次定性FIT)。试验组中有59例接受了肠镜检查,对照组中有36例接受了肠镜检查。结果  试验组的初筛阳性率为25.93%83例),对照组的初筛阳性率为18.77%55例),差异有统计学意义(P=0.034)。试验组接受肠镜检查的人群中,病变(CRC或结直肠腺瘤)的检出率为83.05%49例),对照组接受肠镜检查的人群中,病变(CRC或结直肠腺瘤)的检出率为63.89%23例),差异有统计学意义(P=0.032)。受试者操作特征曲线(receiver operator characteristic curve, ROC曲线)分析显示,定量FIT 筛查早期肠道病变的曲线下面积为0.842P=0.00295%CI 0.695~0.989)。结论  定量FIT在社区CRC筛查中的应用价值高。

 

关键词: 定量免疫粪便隐血试验;社区;结直肠癌

 

Abstract

Objective  To explore the application value of quantitative fecal immunochemical testing (FIT) combined with risk assessment in colorectal cancer (CRC) screening in community. Method  The population screened for CRC in Wujiang District from September 2022 to December 2022 was selected as the research objects. There were 613 positive cases based on the evaluation results, and among these positive patients, 320 cases were selected in the experimental group (1 qualitative FIT +1 quantitative FIT) and 293 cases were selected in the control group (2 qualitative FIT). A total of 59 people in the experimental group underwent colonoscopy, while 36 people in the control group underwent colonoscopy. Result  The positive rate of initial screening in the experimental group was 25.93%(n=83), while that of the control group was 18.77%(n=55), the difference was statistically significant (P=0. 034). Among those undergoing colonoscopy, the detection rate of lesions (CRC or colorectal adenoma) was 83.05% (n=49) in the experimental group and 63.89% (n=23) in the control group, the difference was statistically significant (P=0.032). Receiver operator characteristic curve (ROC curve) analysis showed that the area under the curve of quantitative FIT for early intestinal lesions screening was 0.842 (P=0.002, 95% CI 0.695 -0.989). Conclusion  Quantitative FIT has high application value in CRC screening in community.

 

Key Words:  Quantitative fecal immunochemical testing; Community; Colorectal cancer

 

上一篇:暂无上一篇

下一篇:暂无下一篇

友情链接
中国科学文献服务系统 中国期刊全文数据库 美国生物医学信息检索系统
E-mail
digestiveoncology@163.com
联系电话
020-87616240
编辑部地址
地址:广州越秀区中山二路58号5号楼19楼胃肠外科中心

关注我们

粤ICP备10090623号 技术支持:中网科技